Cellebrite set to report earnings as AI rollout accelerates

Cellebrite DI reports first-quarter results before the market opens Thursday, offering investors a first look at whether the digital forensics company’s aggressive artificial intelligence product launches are translating into accelerating revenue growth.

Analysts expect the company to post earnings of 6.5 cents a on revenue of $127.01 million, representing an 18% jump in sales from the year-ago period. However, the EPS forecast marks a 7.4% year-over-year decline and a sharp drop from the fourth quarter’s 14-cent result, raising questions near-term profitability as Cellebrite invests heavily in new AI capabilities.

Cellebrite launched AI platforms Genesis and Guardian Investigate in March 2026, marking a significant product cycle for the Petah Tikva, Israel-based company. The releases expand the firm’s digital intelligence platform with agentic AI solutions designed to accelerate criminal investigations. EPS estimates have remained flat over the past 60 days, suggesting analysts are taking a wait-and-see approach to the new products’ financial impact.

Wall Street remains bullish on Cellebrite’s long-term prospects. All seven analysts covering the stock rate it a Strong Buy, with a mean price target of $21.67 implying 70% upside from the current $12.74 price. The stock trades near its 52-week low of $11.02, well off last year’s high of $20.45, giving the company a market capitalization of $3.18 billion.

What Investors Are Watching

The company’s recent FedRAMP High Authorization for its Government Cloud platform, achieved on May 6 with the U.S. Department of Justice as the authorizing agency, could unlock significant federal sales. Investors will listen for management commentary on pipeline activity and early contract wins stemming from this milestone, which enables expedited approvals across federal agencies.

Profitability trajectory remains in focus. While revenue is expected to grow 18% year-over-year, the anticipated EPS decline suggests margin pressure from research and development spending. Cellebrite’s gross margin stands at a healthy 84.2%, but operating leverage will be critical as the company scales its new AI products.

Industry data shows 97% of investigators now cite smartphones as the top source of digital evidence, up 24 percentage points from 73% in 2024, underscoring the expanding addressable market for Cellebrite’s mobile forensics solutions.

In the prior quarter, Cellebrite delivered a robust beat, posting adjusted EPS of 14 cents versus the 11-cent consensus and revenue of $128.8 million against expectations of $125.9 million. That 27% earnings surprise and 2.3% revenue beat demonstrated solid execution heading into the new product launches.

Thursday’s results will test whether Cellebrite can balance growth investments with profitability expectations while providing visibility into how Genesis and Guardian Investigate are resonating with law enforcement and corporate customers in an expanding market.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Join our investing challenges and compete for rewards while you learn!